Clinical Trial Update: Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates combining peripheral blood stem cells with mesenchymal stem cells to treat poor graft function after hematopoietic stem ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Diseases

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)
• Peripheral blood stem cells (peripheral blood stem cells)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Stem Cell Transplantation, Hematopoietic, Poor Graft Function | Phase 2 | Status: UNKNOWN